UZ Leuven

• Treat-CMV Ended
  2022-500714-25-01 Phase III 1 country VALACICLOVIR
• The effect of strict blood glucose control within normal fasting ranges, with insulin adjusted according to the Leuven algorithm, in adult c… Ended
  2023-510358-17-00 Phase III 1 country
• Frozen-thawed embryo transfer in a natural versus artificial cycle: a randomized clinical trial. Ended
  2024-511890-30-03 Phase IV 1 country ESTRADIOL VALERATE; PROGESTERONE, MICRONISED
• Neurogenic inflammation upon AITC-induced TRPA1 activation Ended
  2025-520494-40-00 Phase I (Other) 1 country
• Midazolam and morphine to alleviate symptoms at the end of life in patients on acute geriatric wards Ended
  2024-517763-22-00 Phase IV 1 country
• Double-blind placebo-controlled cross-over MRI study to evaluate the effect of naloxegol and codeine on gastrointestinal motility and volume… Ended
  2024-512673-28-00 Phase IV 1 country CODEINE PHOSPHATE HEMIHYDRATE
• Perioperative oral analgesia versus intravenous analgesia for knee arthroscopy, a randomized, double-blinded, non-inferiority trial. OVIKA-t… Ended
  2024-510789-17-00 Phase IV 1 country SODIUM CHLORIDE
• In vivo PET of synaptic density in cognitive disorders: prospective evaluation of neuronal dysfunction and relation to symptomatology. Ended
  2024-514577-22-00 Phase I (Other) 1 country
• SAFE study: Stopping Antibiotics after 3 days for the treatment of FEbrile Neutropenia in Haematology patients, a randomized open-label non-… Ended
  2022-500389-84-00 Phase IV 1 country
• Effect of cannabidiol on muscle recovery following a single bout of resistance exercise. Ended
  2024-513768-24-00 Phase I (Other) 1 country
• Clindamycin pharmacokinetics during obstetric or fetal surgery Ended
  2023-503653-35-00 Phase IV 1 country CLINDAMYCIN PHOSPHATE
• A phase IV, randomized double blinded placebo-controlled study on the barrier restoring capacity of Dupilumab in type 2 airway disease: CRSw… Ended
  2023-504014-30-00 Phase IV 1 country DUPILUMAB
• Pilot study RCT anti-TNF Adalimumab versus placebo in fasciotomy Dupuytren contracture Ended
  2023-503701-11-00 Phase III 1 country
• Outcome measures in SMA patients treated with Risdiplam. Ended
  2022-501760-17-00 Phase III 1 country RISDIPLAM
• Primary carE PPi dEprescRibing (PEPPER) trial Ended
  2022-502375-37-00 Phase IV 1 country ALUMINIUM OXIDE, HYDRATED, ALUMINIUM OXIDE, MAGNESIUM HYDROXIDE; ALUMINIUM OXIDE…
• Patient reported efficacy of intranasal lysine-aspirin in controlling NSAID-exacerbated respiratory disease. Ended
  2024-517437-40-00 Phase II 1 country SODIUM CHLORIDE
• MoodBugs_Rifaximin Ended
  2024-517808-11-00 Phase II 1 country RIFAXIMIN
• Investigating the role of JAK inhibition in achieving and maintaining disease remission in psoriatic arthritis (PsA). Ended
  2024-511401-40-00 Phase IV 1 country TOFACITINIB
• Buspirone for weak or absent esophageal peristalsis Ended
  2024-516667-91-00 Phase IV 1 country BUSPIRONE HYDROCHLORIDE
• Durvalumab (MEDI4736 ) plus tremelimumab in resectable, locally advanced squamous cell carcinoma of the oral cavity: a window of opportunity… Ended
  2024-511511-25-00 Phase I/II 1 country CISPLATIN; DURVALUMAB; TREMELIMUMAB
• Comparison of treatment with preservative-free dexamethasone 0.1% (Monofree Dexamethason) and diclofenac 0.1% (Dicloabak) eye drops versus p… Ended
  2024-517572-38-00 Phase IV 1 country DEXAMETHASONE; DEXAMETHASONE PHOSPHATE; DICLOFENAC SODIUM
• RCT part: COBRA-Slim with or without fast access to TNF blockade for remission induction in early RA. LTE part: Long Term observational fol… Ended
  2023-510189-28-00 Phase IV 1 country ETANERCEPT

Showing 49–70 of 70 trials